Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas.
Major A, Kline J, Karrison TG, Fishkin PAS, Kimball AS, Petrich AM, Nattam S, Rao K, Sleckman BG, Cohen K, Besien KV, Rapoport AP, Smith SM.
Major A, et al. Among authors: rao k.
Haematologica. 2022 Jul 1;107(7):1608-1618. doi: 10.3324/haematol.2021.278853.
Haematologica. 2022.
PMID: 34320785
Free PMC article.
Clinical Trial.